Volume 21 Number 10
31 October 2019

Home > Publications > Current Neuro-Oncology > Volume 21, Year 2019 > Number 10, 31 October

Potharaju M, Mathavan A, Mangaleswaran B, Ghosh S, John R.
Delay in adjuvant chemoradiation impacts survival outcome in glioblastoma multiforme patients.
Acta Oncol. 2019 Oct 1, 2020;59(3):320-323. doi: 10.1080/0284186X.2019.1672893. PMID: 31573367. Observational study. ˍ

Sheikh S, Radivoyevitch T, Barnholtz-Sloan JS, Vogelbaum M.
Long-term trends in glioblastoma survival: implications for historical control groups in clinical trials.
Neurooncol Pract. 2019 Oct 1, 2020;7(2):158-163. doi: 10.1093/nop/npz046. PMID: 32626584. Observational study. ˍ

Tian S, Sudmeier LJ, Zhang C, Madden NA, Buchwald ZS, Shu HG, Curran WJ, Eaton BR, Esiashvili N.
Reduced-volume tumor-bed boost is not associated with inferior local control and survival outcomes in high-risk medulloblastoma.
Pediatr Blood Cancer. 2019 Oct 1, 2020;67(1):e28027. doi: 10.1002/pbc.28027. PMID: 31571408. Observational study. ˍ

Chung SY, Han JW, Kim DS, Yoon HI, Suh CO.
Treatment outcomes based on radiation therapy fields for bifocal germinoma: Synchronous or disseminated disease?
PLoS One. 2019 Oct 3, 2019;14(10):e0223481. doi: 10.1371/journal.pone.0223481. PMID: 31581215. Observational study. ˍ

Bodensohn R, Hadi I, Fleischmann DF, Corradini S, Thon N, Rauch J, Belka C, Niyazi M.
Bevacizumab as a treatment option for radiation necrosis after cranial radiation therapy: a retrospective monocentric analysis.
Strahlenther Onkol. 2019 Oct 4, 2020;196(1):70-76. doi: 10.1007/s00066-019-01521-x. PMID: 31586230. Observational study. ˍ

Senders JT, Staples P, Mehrtash A, Cote DJ, Taphoorn MJB, Reardon DA, Gormley WB, Smith TR, Broekman ML, Arnaout O.
An Online Calculator for the Prediction of Survival in Glioblastoma Patients Using Classical Statistics and Machine Learning.
Neurosurgery. 2019 Oct 5, 2020;86(2):E184-E192. doi: 10.1093/neuros/nyz403. PMID: 31586211. Observational study. ˍ

Berendsen S, van Bodegraven E, Seute T, Spliet WGM, Geurts M, Hendrikse J, Schoysman L, Huiszoon WB, Varkila M, Rouss S, Bell EH, Kroonen J, Chakravarti A, Bours V, Snijders TJ, Robe PA.
Adverse prognosis of glioblastoma contacting the subventricular zone: Biological correlates.
PLoS One. 2019 Oct 11, 2019;14(10):e0222717. doi: 10.1371/journal.pone.0222717. PMID: 31603915. Observational study. ˍ

Gupta M, Choudhury PS, Premsagar IC, Gairola M, Ahlawat P.
Role of 68Ga-Prostate-Specific Membrane Antigen PET/CT in Disease Assessment in Glioblastoma Within 48 Hours of Surgery.
Clin Nucl Med. 2019 Oct 12, 2020;45(3):204-205. doi: 10.1097/RLU.0000000000002893. PMID: 31977462. Case report. ˍ

Holzapfel J, Kandels D, Schmidt R, Pietsch T, Warmuth-Metz M, Bison B, Krauss J, Kortmann RD, Timmermann B, Thomale UW, Albert MH, Hernáiz Driever P, Witt O, Gnekow AK.
Favorable prognosis in pediatric brainstem low-grade glioma - report from the German SIOP-LGG 2004 cohort.
Int J Cancer. 2019 Oct 15. 2020;146(12):3385-3396. doi: 10.1002/ijc.32734. PMID: 31613986. Observational study. ˍ

Doyle J, Khalafallah AM, Yang W, Sun Y, Bettegowda C, Mukherjee D.
Association between extent of resection on survival in adult brainstem high-grade glioma patients.
J Neurooncol. 2019 Oct 16, 2019;145(3):479-486. doi: 10.1007/s11060-019-03313-w. PMID: 31621041. Observational study. ˍ

Jansen E, Hamisch C, Ruess D, Heiland DH, Goldbrunner R, Ruge MI, Schnell O, Grau SJ.
Observation after surgery for low grade glioma: long-term outcome in the light of the 2016 WHO classification.
J Neurooncol. 2019 Oct 16, 2019;145(3):501-507. doi: 10.1007/s11060-019-03316-7. PMID: 31621043. Observational study. ˍ


Valiakhmetova A, Gorelyshev S, Konovalov A, Trunin Y, Savateev A, Kram DE, Severson E, Hemmerich A, Edgerly C, Duncan D, Britt N, Huang RSP, Elvin J, Miller V, Ross JS, Gay L, McCorkle J, Rankin A, Erlich RL, Chudnovsky Y, Ramkissoon SH.
Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2-Year Durable Response.
Oncologist. 2019 Oct 16, 2020;25(2):e198-e202. doi: 10.1634/theoncologist.2019-0603. PMID: 32043779. Case report. ˍ

Yeo KK, Margol AS, Kennedy RJ, Hung L, Robison NJ, Dhall G, Asgharzadeh S.
Prognostic significance of molecular subgroups of medulloblastoma in young children receiving irradiation-sparing regimens.
J Neurooncol. 2019 Oct 16, 2019;145(2):375-383. doi: 10.1007/s11060-019-03307-8. PMID: 31621042. Observational study. ˍ

Gittleman H, Sloan AE, Barnholtz-Sloan JS.
An independently validated survival nomogram for lower grade glioma.
Neuro Oncol. 2019 Oct 17, 2020;22(5):665-674. doi: 10.1093/neuonc/noz191. PMID: 31621885. Observational study. ˍ

Mazzatenta D, Zoli M, Guaraldi F, Ambrosi F, Fustini MF, Pasquini E, Asioli S, Zucchelli M.
Outcome of endoscopic endonasal surgery in pediatric craniopharyngiomas.
World Neurosurg. 2019 Oct 17, 2020;134:e277-e288. doi: 10.1016/j.wneu.2019.10.039. PMID: 31629927. Observational study. ˍ

Le Rhun E, Devos P, Bourg V, Darlix A, Lorgis V, Ahle G, Boone M, Taillandier L, Curtit E, Gras L, Lebrun Frenay C, Gramatzki D, Ramirez C, Simon N, Weller M.
Complementary and alternative medicine use in glioma patients in France.
J Neurooncol. 2019 Oct 21, 2019;145(3):487-499. doi: 10.1007/s11060-019-03315-8. PMID: 31637628. Observational study. ˍ

Carey SS, Sadighi Z, Wu S, Chiang J, Robinson GW, Ghazwani Y, Liu APY, Acharya S, Merchant TE, Boop FA, Gajjar A, Qaddoumi I.
Evaluating pediatric spinal low-grade gliomas: a 30-year retrospective analysis.
J Neurooncol. 2019 Oct 22, 2019;145(3):519-529. doi: 10.1007/s11060-019-03319-4. PMID: 31642023. Observational study. ˍ

Heenkenda MK, Malmström A, Lysiak M, Mudaisi M, Bratthäll C, Milos P, Strandeus M, Åkesson L, Söderkvist P, Uppugunduri S, Osman A.
Assessment of genetic and non-genetic risk factors for venous thromboembolism in glioblastoma - The predictive significance of B blood group.
Thromb Res. 2019 Oct 22, 2019;183:136-142. doi: 10.1016/j.thromres.2019.10.009. PMID: 31677594. Observational study. ˍ

Youssef M, Ludmir EB, Mandel JJ, Patel AJ, Jalali A, Treiber J, Wu J, McAleer MF, de Groot JF.
Treatment strategies for glioblastoma in older patients: age is just a number.
J Neurooncol. 2019 Oct 23, 2019;145(2):357-364. doi: 10.1007/s11060-019-03304-x. PMID: 31643011. Observational study. ˍ

Prayson RA.
IDH-1 polymorphisms in pilocytic astrocytomas.
Ann Diagn Pathol. 2019 Oct 23, 2019;43:151411. doi: 10.1016/j.anndiagpath.2019.151411. PMID: 31677487. Case report. ˍ

Mukherjee S, Wood J, Liaquat I, Stapleton SR, Martin AJ.
Craniotomy for recurrent glioblastoma: Is it justified? A comparative cohort study with outcomes over 10 years.
Clin Neurol Neurosurg. 2019 Oct 24;188:105568. doi: 10.1016/j.clineuro.2019.105568. PMID: 31739155. Observational study. ˍ

Ahmadipour Y, Rauschenbach L, Gembruch O, Darkwah Oppong M, Michel A, Pierscianek D, Stuschke M, Glas M, Sure U, Jabbarli R.
To resect or not to resect? Risks and benefits of surgery in older patients with glioblastoma.
J Geriatr Oncol. 2019 Oct 28, 2020;11(4):688-693. doi: 10.1016/j.jgo.2019.10.013. PMID: 31672557. Observational study. ˍ

Hwang K, Kim TM, Park CK, Chang JH, Jung TY, Kim JH, Nam DH, Kim SH, Yoo H, Hong YK, Kim EY, Lee DE, Joo J, Kim YJ, Choe G, Choi BS, Kang SG, Kim JH, Kim CY.
Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study).
Cancer Res Treat. 2019 Oct 28, 2020;52(2):505-515. doi: 10.4143/crt.2019.421. PMID: 31671938. Interventional study. ˍ

Reinhardt A, Stichel D, Schrimpf D, Koelsche C, Wefers AK, Ebrahimi A, Sievers P, Huang K, Casalini MB, Fernández-Klett F, Suwala A, Weller M, Gramatzki D, Felsberg J, Reifenberger G, Becker A, Hans VH, Prinz M, Staszewski O, Acker T, Dohmen H, Hartmann C, Paulus W, Heß K, Brokinkel B, Schittenhelm J, Buslei R, Deckert M, Mawrin C, Hewer E, Pohl U, Jaunmuktane Z, Brandner S, Unterberg A, Hänggi D, Platten M, Pfister SM, Wick W, Herold-Mende C, Korshunov A, Reuss DE, Sahm F, Jones DTW, Capper D, von Deimling A.
Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities.
Acta Neuropathol Commun. 2019 Oct 28, 2019;7(1):163. doi: 10.1186/s40478-019-0801-8. PMID: 31661039. Observational study. ˍ

Ji SY, Kim JW, Park CK.
Experience Profiling of Fluorescence-Guided Surgery I: Gliomas.
Brain Tumor Res Treat. 2019 Oct 29, 2019;7(2):98-104. doi: 10.14791/btrt.2019.7.e38. PMID: 31686440. Observational study. ˍ

Ji SY, Kim JW, Park CK.
Experience Profiling of Fluorescence-Guided Surgery II: Non-Glioma Pathologies.
Brain Tumor Res Treat. 2019 Oct 29, 2019;7(2):105-111. doi: 10.14791/btrt.2019.7.e39. PMID: 31686441. Observational study. ˍ

Park JH, Jung N, Kang SJ, Kim HS, Kim E, Lee HJ, Jung HR, Choe M, Shim YJ.
Survival and Prognosis of Patients with Pilocytic Astrocytoma: A Single-Center Study.
Brain Tumor Res Treat. 2019 Oct 29, 2019;7(2):92-97. doi: 10.14791/btrt.2019.7.e36. PMID: 31686439. Observational study. ˍ

Ganau M, Gallinaro P, Cebula H, Scibilia A, Todeschi J, Gubian A, Nannavecchia B, Signorelli F, Pop R, Coca HA, Proust F, Chibbaro S.
Intracranial Metastases from Prostate Carcinoma: Classification, Management, and Prognostication.
World Neurosurg.
2019 Oct 31, 2020;134:e559-e565. doi: 10.1016/j.wneu.2019.10.125. PMID: 31678450. Observational study. ˍ

Marton E, Giordan E, Siddi F, Curzi C, Canova G, Scarpa B, Guerriero A, Rossi S, D' Avella D, Longatti P, Feletti A.
Over ten years overall survival in glioblastoma: A different disease?
J Neurol Sci. 2019 Oct 31, 2020;408:116518. doi: 10.1016/j.jns.2019.116518. PMID: 31715330. Observational study. ˍ